@ARTICLE{
author={Bar-Or Amit,Oh J,Dufek Michal,Budincevic Hrvoje,Habek Mario,Caunt Maresa,Harp C,Sierzega M,Clayton David,Chen Y,Ratchford JN,Goodyear Alexandra,Drulovic Jelena S},
year={2025},
title={Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Clinical, Safety and Biomarker Results From the FENopta Open-Label Extension},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={31},
number={2_SUPPL},
pages={244-244},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Hua Le,Bar-Or Amit,Weber Martin,Habek Mario,Budincevic Hrvoje,Thomas Piia,Napieralski Julie,Ratchford John,Qi Qi,Sierzega M,Drulovic Jelena S},
year={2023},
title={Efficacy and Safety of Fenebrutinib, a Noncovalent, Reversible BTK inhibitor, in MS: Primary Results of a Phase 2 Trial},
journal={EUROPEAN JOURNAL OF NEUROLOGY},
volume={30},
number={},
pages={-},
document_type={Meeting Abstract},
}